Rekah Pharmaceutical Industry Ltd.

TASE:REKA 株式レポート

時価総額:₪167.1m

Rekah Pharmaceutical Industry バランスシートの健全性

財務の健全性 基準チェック /46

Rekah Pharmaceutical Industryの総株主資本は₪169.2M 、総負債は₪94.0Mで、負債比率は55.6%となります。総資産と総負債はそれぞれ₪451.8Mと₪282.7Mです。 Rekah Pharmaceutical Industryの EBIT は₪18.1Mで、利息カバレッジ比率2.7です。現金および短期投資は₪5.4Mです。

主要情報

55.6%

負債資本比率

₪93.97m

負債

インタレスト・カバレッジ・レシオ2.7x
現金₪5.45m
エクイティ₪169.15m
負債合計₪282.68m
総資産₪451.83m

財務の健全性に関する最新情報

Recent updates

Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) Shares Climb 30% But Its Business Is Yet to Catch Up

Jul 11
Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) Shares Climb 30% But Its Business Is Yet to Catch Up

Here's Why Rekah Pharmaceutical Industry (TLV:REKA) Has A Meaningful Debt Burden

Jul 05
Here's Why Rekah Pharmaceutical Industry (TLV:REKA) Has A Meaningful Debt Burden

Here's Why Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) CEO May Not Expect A Pay Rise This Year

Dec 14
Here's Why Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) CEO May Not Expect A Pay Rise This Year

Rekah Pharmaceutical Industry (TLV:REKA) Has A Somewhat Strained Balance Sheet

Sep 12
Rekah Pharmaceutical Industry (TLV:REKA) Has A Somewhat Strained Balance Sheet

Estimating The Fair Value Of Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

Jul 19
Estimating The Fair Value Of Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

Rekah Pharmaceutical Industry's (TLV:REKA) Problems Go Beyond Weak Profit

Apr 13
Rekah Pharmaceutical Industry's (TLV:REKA) Problems Go Beyond Weak Profit

We Think Rekah Pharmaceutical Industry (TLV:REKA) Is Taking Some Risk With Its Debt

May 12
We Think Rekah Pharmaceutical Industry (TLV:REKA) Is Taking Some Risk With Its Debt

Here's Why I Think Rekah Pharmaceutical Industry (TLV:REKA) Might Deserve Your Attention Today

Apr 09
Here's Why I Think Rekah Pharmaceutical Industry (TLV:REKA) Might Deserve Your Attention Today

Does Rekah Pharmaceutical Industry's (TLV:REKA) Share Price Gain of 50% Match Its Business Performance?

Mar 12
Does Rekah Pharmaceutical Industry's (TLV:REKA) Share Price Gain of 50% Match Its Business Performance?

Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Feb 19
Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Is Rekah Pharmaceutical Industry (TLV:REKA) Using Too Much Debt?

Jan 29
Is Rekah Pharmaceutical Industry (TLV:REKA) Using Too Much Debt?

Here's Why I Think Rekah Pharmaceutical Industry (TLV:REKA) Is An Interesting Stock

Jan 08
Here's Why I Think Rekah Pharmaceutical Industry (TLV:REKA) Is An Interesting Stock

How Is Rekah Pharmaceutical Industry's (TLV:REKA) CEO Paid Relative To Peers?

Dec 18
How Is Rekah Pharmaceutical Industry's (TLV:REKA) CEO Paid Relative To Peers?

Investors Who Bought Rekah Pharmaceutical Industry (TLV:REKA) Shares Five Years Ago Are Now Up 33%

Nov 30
Investors Who Bought Rekah Pharmaceutical Industry (TLV:REKA) Shares Five Years Ago Are Now Up 33%

財務状況分析

短期負債: REKAの 短期資産 ( ₪225.0M ) が 短期負債 ( ₪151.0M ) を超えています。

長期負債: REKAの短期資産 ( ₪225.0M ) が 長期負債 ( ₪131.7M ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: REKAの 純負債対資本比率 ( 52.3% ) は 高い と見なされます。

負債の削減: REKAの負債対資本比率は、過去 5 年間で58.6%から55.6%に減少しました。

債務返済能力: REKAの負債は 営業キャッシュフロー によって 十分にカバー されています ( 25.7% )。

インタレストカバレッジ: REKAの負債に対する 利息支払いEBIT ( 2.7 x coverage) によって 十分にカバーされていません


貸借対照表


健全な企業の発掘